Abstract
Advances in the development of highly infectious, replication-deficient recombinant retroviruses provide an efficient means of stable transfer of gene expression. Coupled with ex vivo transduction, surrogate cell populations can be readily implanted into the brain, thus serving as vehicles for delivering selected gene products into the central nervous system (CNS). Here we report that rat astrocytes can be routinely and safely isolated from brain tissue of a living donor by use of short-term gelatin sponge implants. The mature, nontransformed astrocytes were easily expanded, maintained in long-term tissue cultures and were efficiently transduced with an amphotropic retrovirus harboring a heterologous, fused transgene. In vitro retroviral infection rendered the nontransformed cells essentially 100% viable after exposure. The level of efficiency of infection (30–50% effective genome integration of provirus and expression of transgene in target cell populations) and minimal cell toxicity obviated the need to harvest large numbers of target cells. Cultured transduced astrocytes were resilient and exhibited select peptide expression for up to 1 year. Subsequently, transduced astrocytes were used in a series of experiments in which cells were transplanted intracerebrally in syngeneic animals. Post-implantation, astrocytes seeded locally and either insinuated into the surrounding parenchyma in situ or exhibited a variable degree of migration, depending on the anatomic source of astrocytes and the targeted brain implantation site. Transduced astrocytes remained viable in excess of 8 months post-transplantation and exhibited sustained transgenic peptide expression of green fluorescent protein/neomycin phosphotransferase in vivo. The sequential isolation and culture of nontransformed, mature, adult astrocytes and recombinant retrovirus-mediated transduction in vitro followed by brain reimplantation represents a safe and effective means for transferring genetic expression to the CNS. This study lays the foundation for exploring the utility of using a human autologous transplantation system as a potential gene delivery approach to treat neurological disorders. Prepared and utilized in this manner, autologous astrocytes may serve as a vehicle to deliver gene therapy to the CNS.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
$259.00 per year
only $43.17 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout










Similar content being viewed by others
References
Friedmann T. . Gene therapy for neurological disorders TIG 1994 10: 210–210
Doering L.C. . Nervous system modification by transplants and gene transfer BioEssays 1994 16: 825–825
Blomer U. et al. Applications of gene therapy to the CNS Hum Mol Genetics 1996 5: 1397–1397
Robbins P.D., Ghivizzani S.C. . Viral vectors for gene therapy Pharmacol Ther 1998 80: 35–35
Lin Q. et al. Human fetal astrocytes as an ex vivo gene therapy vehicle for delivering biologically active nerve growth factor Hum Gene Ther 1997 8: 331–331
Lundberg C., Horellou P., Mallet J., Bjorklund A. . Generation of DOPA-producing astrocytes by retroviral transduction of the human tyrosine hydroxylase gene: in vitro characterization and in vivo effects in the rat Parkinson model Exp Neurol 1996 139: 39–39
Gage F.H. . Fetal implants put to the test Nature 1993 361: 405–405
Widner H. et al. Bilateral fetal mesencephalic grafting in two patients with Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) New Engl J Med 1992 327: 1556–1556
Flax J.D. et al. Engraftable human neural stem cells respond to developmental cues replace neurons, and express foreign genes Nat Biotechnol 1998 16: 1033–1033
Lacorazza R.D. et al. Expression of human beta-hexosaminidase alpha-subunit in mouse brains upon engraftment of transduced progenitor cells Nature Med 1996 2: 424–424
Cunningham L.A., Short M.P., Breakefield X.O., Bohn M.C. . Nerve growth factor released by transgenic astrocytes enhances the function of adrenal chromaffin cell grafts in a rat model of Parkinson's disease Brain Res 1994 658: 219–219
Ljungberg M.C., Stern G., Wilkin G.P. . Survival of genetically engineered, adult-derived rat astrocytes grafted into the 6-hydroxydopamine lesioned adult rat striatum Brain Res 1999 816: 29–29
Tornatore C. et al. Expression of tyrosine hydroxylase in an immortalized human fetal astrocyte cell line; in vitro characterization and engraftment into the rodent striatum Cell Transplant 1996 5: 145–145
Fitoussi N. et al. Dopamine turnover and metabolism in the striatum of Parkinsonian rats grafted with genetically modified human astrocytes Neuroscience 1998 85: 405–405
Tuszynski J. et al. Gene therapy in the adult primate brain: intraparenchymal grafts of cells genetically modified to produce nerve growth factor prevent cholinergic neuronal degeneration Gene Therapy 1996 3: 305–305
Freed W.J., Poltorak M., Becker J.B. . Intracerebral adrenal medulla grafts: a review Exp Neur 1990 110: 139–139
Constantini L.C., Bakowska J.C., Breakefield X.O., Isacson O. . Gene therapy in the CNS Gene Therapy 2000 7: 93–93
Fisher L.J. et al. Survival and function of intrastriatally grafted fibroblasts genetically modified to produce L-dopa Neuron 1991 6: 371–371
Palmer T.D., Rosman G.J., Miller W.R., Miller A.D. . Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes Proc Natl Acad Sci USA 1991 88: 1330–1330
Montgomery D.L. . Astrocytes: form, functions, and roles in disease Vet Pathol 1994 31: 145–145
Rudge J.S., Manthorpe M., Varon S. . The output of neurotrophic and neurite-promoting agents from rat brain astroglial cells: a microculture method for screening potential regulatory agents Brain Res 1985 351: 161–161
Plunkett R.J. et al. Trauma-induced striatal CNTF and BDNF mRNA in hemiparkinsonian rats NeuroReport 1997 8: 507–507
Gage F.H. et al. Intracerebral grafts of embryonic neural cells into the adult host brain: an overview of the cell suspension method and its application Dev Neurosci 1984 6: 137–137
Hatton J.D., Garcia R., U H.S. . Migration of grafted rat astrocytes: dependence on source/target organ Glia 1992 5: 251–251
Chu J., Hatton J.D., U H.S. . Effects of epidermal growth factor and dibutyryl cyclic adenosine monophosphate on the migration pattern of astrocytes grafted into adult rat brain Neurosurgery 1999 45: 859–859
Ridet J.L. et al. Toward autologous ex vivo gene therapy for the central nervous system with human adult astrocytes Hum Gene Ther 1999 10: 271–271
Langan T.J. et al. Long-term production of neurotrophic factors by astrocyte cultures from hemiparkinsonian rat brain Glia 1995 14: 174–174
Veetai L., Kelly K., Schrot R., Langan T.J. . Cell cycle kinetics and commitment in newborn, adult and tumoral astrocytes Dev Brain Res 1996 96: 138–138
Miller D.A., Buttimore C. . Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production Mol Cell Biol 1985 6: 2895–2895
Paxinos G, Watson W . The Rat Brain in Stereotaxic Coordinates Academic Press 1997
Acknowledgements
The authors wish to express their appreciation to Ms Grace Lombardo for expert secretarial support in the preparation of this manuscript. Atlas figures were reproduced from The Rat Brain with permission from Paxinos and Watson. This work was supported in part by grants from the Endowment for the Neurosciences and from the Roswell Park Alliance Foundation.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Selkirk, S., Greenberg, S., Plunkett, R. et al. Syngeneic central nervous system transplantation of genetically transduced mature, adult astrocytes. Gene Ther 9, 432–443 (2002). https://doi.org/10.1038/sj.gt.3301643
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.gt.3301643
Keywords
This article is cited by
-
Recovery of Neurovascular Unit Integrity by CDK5-KD Astrocyte Transplantation in a Global Cerebral Ischemia Model
Molecular Neurobiology (2018)
-
Neuroprotection Induced by Transplanted CDK5 Knockdown Astrocytes in Global Cerebral Ischemic Rats
Molecular Neurobiology (2017)
-
EGF Receptor Activation Decreases Retroviral Gene Transfer through Protein Kinase C-δ
Molecular Therapy (2007)


